Mycobacterium avium Complex
"Mycobacterium avium Complex" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs.
| Descriptor ID |
D015269
|
| MeSH Number(s) |
B03.510.024.049.525.500.720.100 B03.510.460.400.410.552.552.720.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium avium Complex".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium avium Complex".
This graph shows the total number of publications written about "Mycobacterium avium Complex" by people in this website by year, and whether "Mycobacterium avium Complex" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium avium Complex" by people in Profiles.
-
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion. BMC Infect Dis. 2022 Mar 12; 22(1):246.
-
Disseminated Nontuberculous Mycobacterium Presenting as Chronic Diarrhea and Wasting. J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10:23247096221101860.
-
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial. Ann Am Thorac Soc. 2021 07; 18(7):1147-1157.
-
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest. 2021 09; 160(3):831-842.
-
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 12 15; 198(12):1559-1569.
-
Nontuberculous Mycobacteria in Cystic Fibrosis. Semin Respir Crit Care Med. 2018 Jun; 39(3):383-391.
-
Bioactive Formylated Flavonoids from Eugenia rigida: Isolation, Synthesis, and X-ray Crystallography. J Nat Prod. 2016 09 23; 79(9):2341-9.
-
Antileishmanial metabolites from Geosmithia langdonii. J Nat Prod. 2014 Sep 26; 77(9):1987-91.
-
Structure-activity relationship studies of manzamine A: amidation of positions 6 and 8 of the beta-carboline moiety. Bioorg Med Chem. 2009 Nov 15; 17(22):7775-82.
-
Scalarane sesterterpenoids: semisynthesis and biological activity. J Nat Prod. 2009 Aug; 72(8):1492-6.